165 related articles for article (PubMed ID: 23203906)
1. Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis.
Bonelli M; Ferner E; Göschl L; Blüml S; Hladik A; Karonitsch T; Kiener HP; Byrne R; Niederreiter B; Steiner CW; Rath E; Bergmann M; Smolen JS; Scheinecker C
Arthritis Rheum; 2013 Mar; 65(3):599-607. PubMed ID: 23203906
[TBL] [Abstract][Full Text] [Related]
2. Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis.
Bonelli M; Göschl L; Blüml S; Karonitsch T; Hirahara K; Ferner E; Steiner CW; Steiner G; Smolen JS; Scheinecker C
Rheumatology (Oxford); 2016 Apr; 55(4):710-20. PubMed ID: 26672908
[TBL] [Abstract][Full Text] [Related]
3. T cell lessons from the rheumatoid arthritis synovium SCID mouse model: CD3-rich synovium lacks response to CTLA-4Ig but is successfully treated by interleukin-17 neutralization.
Koenders MI; Marijnissen RJ; Joosten LA; Abdollahi-Roodsaz S; Di Padova FE; van de Loo FA; Dulos J; van den Berg WB; Boots AM
Arthritis Rheum; 2012 Jun; 64(6):1762-70. PubMed ID: 22213107
[TBL] [Abstract][Full Text] [Related]
4. Impact of the CTLA-4/CD28 axis on the processes of joint inflammation in rheumatoid arthritis.
Körmendy D; Hoff H; Hoff P; Bröker BM; Burmester GR; Brunner-Weinzierl MC
Arthritis Rheum; 2013 Jan; 65(1):81-7. PubMed ID: 23045162
[TBL] [Abstract][Full Text] [Related]
5. Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion.
Moreland LW; Alten R; Van den Bosch F; Appelboom T; Leon M; Emery P; Cohen S; Luggen M; Shergy W; Nuamah I; Becker JC
Arthritis Rheum; 2002 Jun; 46(6):1470-9. PubMed ID: 12115176
[TBL] [Abstract][Full Text] [Related]
6. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated gene transfer of CTLA-4Ig fusion protein in the suppression of experimental autoimmune arthritis.
Quattrocchi E; Dallman MJ; Feldmann M
Arthritis Rheum; 2000 Aug; 43(8):1688-97. PubMed ID: 10943858
[TBL] [Abstract][Full Text] [Related]
8. CTLA-4Ig suppresses liver injury by inhibiting acquired immune responses in a mouse model of fulminant hepatitis.
Nakayama Y; Shimizu Y; Hirano K; Ebata K; Minemura M; Watanabe A; Sugiyama T
Hepatology; 2005 Oct; 42(4):915-24. PubMed ID: 16175605
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T lymphocyte-associated antigen-4-Ig (CTLA-4-Ig) suppresses Staphylococcus aureus-induced CD80, CD86, and pro-inflammatory cytokine expression in human B cells.
Liu PC; Ssu CT; Tsao YP; Liou TL; Tsai CY; Chou CT; Chen MH; Leu CM
Arthritis Res Ther; 2020 Mar; 22(1):64. PubMed ID: 32228715
[TBL] [Abstract][Full Text] [Related]
10. Abatacept mechanism of action: concordance with its clinical profile.
Herrero-Beaumont G; Martínez Calatrava MJ; Castañeda S
Reumatol Clin; 2012; 8(2):78-83. PubMed ID: 22104048
[TBL] [Abstract][Full Text] [Related]
11. Functional differentiation of dendritic cells in rheumatoid arthritis: role of CD86 in the synovium.
Thomas R; Quinn C
J Immunol; 1996 Apr; 156(8):3074-86. PubMed ID: 8609431
[TBL] [Abstract][Full Text] [Related]
12. CTLA-4Ig blocks the development and progression of citrullinated fibrinogen-induced arthritis in DR4-transgenic mice.
Yue D; Brintnell W; Mannik LA; Christie DA; Haeryfar SM; Madrenas J; Chakrabarti S; Bell DA; Cairns E
Arthritis Rheum; 2010 Oct; 62(10):2941-52. PubMed ID: 20533540
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4IG suppresses reactive oxygen species by preventing synovial adherent cell-induced inactivation of Rap1, a Ras family GTPASE mediator of oxidative stress in rheumatoid arthritis T cells.
Remans PH; Wijbrandts CA; Sanders ME; Toes RE; Breedveld FC; Tak PP; van Laar JM; Reedquist KA
Arthritis Rheum; 2006 Oct; 54(10):3135-43. PubMed ID: 17009234
[TBL] [Abstract][Full Text] [Related]
14. ICOS and B7 costimulatory molecule expression identifies activated cellular subsets in rheumatoid arthritis.
Ruth JH; Rottman JB; Kingsbury GA; Coyle AJ; Haines GK; Pope RM; Koch AE
Cytometry A; 2007 May; 71(5):317-26. PubMed ID: 17323353
[TBL] [Abstract][Full Text] [Related]
15. CTLA-4Ig: uses and future directions.
Ben-Shoshan M
Recent Pat Inflamm Allergy Drug Discov; 2009 Jun; 3(2):132-42. PubMed ID: 19519590
[TBL] [Abstract][Full Text] [Related]
16. Blood PD-1+TFh and CTLA-4+CD4+ T cells predict remission after CTLA-4Ig treatment in early rheumatoid arthritis.
Aldridge J; Andersson K; Gjertsson I; Hultgård Ekwall AK; Hallström M; van Vollenhoven R; Lundell AC; Rudin A
Rheumatology (Oxford); 2022 Mar; 61(3):1233-1242. PubMed ID: 34009274
[TBL] [Abstract][Full Text] [Related]
17. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
[TBL] [Abstract][Full Text] [Related]
18. Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2.
Webb LM; Walmsley MJ; Feldmann M
Eur J Immunol; 1996 Oct; 26(10):2320-8. PubMed ID: 8898940
[TBL] [Abstract][Full Text] [Related]
19. The effect of CTLA-4Ig, a CD28/B7 antagonist, on the lung inflammation and T cell subset profile during murine hypersensitivity pneumonitis.
Jiménez-Alvarez L; Arreola JL; Ramírez-Martínez G; Ortiz-Quintero B; Gaxiola M; Reynoso-Robles R; Avila-Moreno F; Urrea F; Pardo A; Selman M; Zuñiga J
Exp Mol Pathol; 2011 Dec; 91(3):718-22. PubMed ID: 21945736
[TBL] [Abstract][Full Text] [Related]
20. Collagen-induced arthritis in the BB rat. Prevention of disease by treatment with CTLA-4-Ig.
Knoerzer DB; Karr RW; Schwartz BD; Mengle-Gaw LJ
J Clin Invest; 1995 Aug; 96(2):987-93. PubMed ID: 7543497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
